Skip to main content

Table 5 AS and DHA recovery after 3 months in accelerated aging conditions (40°C/75%RH)

From: The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership

  AS content (%) DHA content (%)
Arsumax® > 95 3.3
Monolayer ASAQ tablet 97.8 3.4
Bilayer ASAQ tablet 99.1 < LOQ
  1. Comparison between monolayer tablets with pH regulator (batch n° 30411), bilayer high dosage tablets (batch n° 40166) and commercially available reference of AS tablets, Arsumax®